HT1080/Cre cells are derived from the human fibrosarcoma cell line HT1080 by stably integration of a constitutive Cre recombinase stably expression construct. HT1080 cells have been widely used in cancer research and drug development. HT1080/Cre cells stably express a nuclear localized Cre recombinase.